ACCESSION: MSBNK-SMB_Measured-HSA015P0344006
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 12
COMMENT: RAW_SPEC {'EL22_pos_2607': {'bp': 345998.0, 'sum': 560064.0}, 'EL02_pos_2597': {'bp': 316655.0, 'sum': 523551.0}, 'EL08_pos_2595': {'bp': 311253.0, 'sum': 523662.0}, 'EL01_pos_2596': {'bp': 304651.0, 'sum': 490255.0}, 'EL17_pos_2590': {'bp': 242886.0, 'sum': 398992.0}, 'EL12_pos_2579': {'bp': 186435.0, 'sum': 302943.0}, 'EL20_pos_2590': {'bp': 183755.0, 'sum': 326560.0}, 'EL10_pos_2601': {'bp': 182621.0, 'sum': 290124.0}, 'EL09_pos_2585': {'bp': 176077.0, 'sum': 292136.0}, 'EL21_pos_2591': {'bp': 175674.0, 'sum': 302365.0}, 'EL07_pos_2597': {'bp': 147244.0, 'sum': 251659.0}, 'EL14_pos_2597': {'bp': 143484.0, 'sum': 237485.0}}
COMMENT: RETENTION_TIME_STDEV 0.011
COMMENT: PRECURSOR_M/Z_RAW 344.218018
COMMENT: PRECURSOR_M/Z_STDEV 0.000106
COMMENT: PRECURSOR_IN_MS1 mz 344.217999; int 63.090; delta(ppm) 1.212962
COMMENT: PROPOSED_CHARGE_STATE +1; mz 345.220788; int 11.279; cor 1.000
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 4.810; C14H34NO6P; [M+H]+; delta(ppm) -4.810456
COMMENT: PROPOSED_MF SevenGoldenRules 0.003; C16H29N3O5; [M+H]+; delta(ppm) 0.002914
COMMENT: PROPOSED_MF MS-FINDER 3.540; C16H29N3O5; [M+H]+; delta(ppm) 0.001484
COMMENT: PROPOSED_MF MS-FINDER 2.916; C9H29N9O3S; [M+H]+; delta(ppm) -1.990855
COMMENT: PROPOSED_MF MS-FINDER 2.846; C10H30N7O4P; [M+H]+; delta(ppm) 3.004126
COMMENT: PROPOSED_MF MS-FINDER 2.547; C17H25N7O; [M+H]+; delta(ppm) -3.883870
COMMENT: PROPOSED_MF MS-FINDER 2.309; C17H33N3S2; [M+H]+; delta(ppm) -2.523124
COMMENT: PROPOSED_MF MS-FINDER 2.246; C14H34NO6P; [M+H]+; delta(ppm) -4.797099
COMMENT: PROPOSED_MF SIRIUS5_Sirius 15.804; C16H29N3O5; [M+H]+; delta(ppm) 0.001484
COMMENT: PROPOSED_MF SIRIUS5_Sirius 12.531; C17H25N7O; [M+H]+; delta(ppm) -3.883870
COMMENT: PROPOSED_MF SIRIUS5_Sirius 4.694; C20H29N3S; [M+H]+; delta(ppm) 7.270506
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.960; C16H29N3O5; [M+H]+; delta(ppm) 0.001484
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.040; C17H25N7O; [M+H]+; delta(ppm) -3.883870
COMMENT: PROPOSED_MF SIRIUS6_Sirius 25.583; C16H29N3O5; [M+H]+; delta(ppm) 0.001484
COMMENT: PROPOSED_MF SIRIUS6_Sirius 22.310; C17H25N7O; [M+H]+; delta(ppm) -3.883870
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.820; C13H30FN3O6; [M+H]+; delta(ppm) -3.318070
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.586; C13H31N2O8; [M+H]+; delta(ppm) 7.787534
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.820; C12H25N9O3; [M+H]+; delta(ppm) 7.802785
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.894; C14H26FN7O2; [M+H]+; delta(ppm) -7.203398
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.071; C19H28F3NO; [M+H]+; delta(ppm) -4.581246
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.066; C22H25BN2O; [M+H]+; delta(ppm) 29963.837017
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.046; C12H32N4O5P; [M+H]+; delta(ppm) -0.896502
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.178; C19H26BFN2O2; [M+H]+; delta(ppm) 29960.315551
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.961; C16H29N3O5; [M+H]+; delta(ppm) 0.001484
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.038; C17H25N7O; [M+H]+; delta(ppm) -3.883870
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C12H25N9O3; [M+H]+; delta(ppm) 7.802785
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.489; JDKKNZCTQZVUAU-UHFFFAOYSA-N; [M+H]+; S=C(NC1CCCCC1)N2C3=CC=C(C=C3C4CN(C)CCC24)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.429; KMKUXKWHHGYRTE-UHFFFAOYSA-N; [M+H]+; O=C(NCC1OC(CO)C(O)C1N2CCCCC2)N3CCOCC3
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.415; GRCBRFWADWMAHC-UHFFFAOYSA-N; [M+H]+; O=C(NC1COC(CN2CCCC2COC)C1O)N3CCOCC3
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.373; VEEOQPGMBXUVDQ-UHFFFAOYSA-N; [M+H]+; O=C(NCCC)NCC1OC2CC(OC2C1O)CC(=O)NC(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.238; KDSQYJRKKPZTGS-UHFFFAOYSA-N; [M+H]+; O=C(NCC1OC2CC(OC2C1O)CC(=O)NC(C)C)NC(C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.904; KMKUXKWHHGYRTE-UHFFFAOYSA-N; [M+H]+; N-{[4-hydroxy-5-(hydroxymethyl)-3-(piperidin-1-yl)oxolan-2-yl]methyl}morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.863; GRCBRFWADWMAHC-UHFFFAOYSA-N; [M+H]+; N-(4-hydroxy-5-{[2-(methoxymethyl)pyrrolidin-1-yl]methyl}oxolan-3-yl)morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.532; KDSQYJRKKPZTGS-UHFFFAOYSA-N; [M+H]+; 2-[6-hydroxy-5-({[(propan-2-yl)carbamoyl]amino}methyl)-hexahydrofuro[3,2-b]furan-2-yl]-N-(propan-2-yl)acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.532; VEEOQPGMBXUVDQ-UHFFFAOYSA-N; [M+H]+; 2-(6-hydroxy-5-{[(propylcarbamoyl)amino]methyl}-hexahydrofuro[3,2-b]furan-2-yl)-N-(propan-2-yl)acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.532; WAQKSLBVYZATBA-UHFFFAOYSA-N; [M+H]+; 2-[6-hydroxy-5-({[(propan-2-yl)carbamoyl]amino}methyl)-hexahydrofuro[3,2-b]furan-2-yl]-N-propylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; KMKUXKWHHGYRTE-UHFFFAOYSA-N; [M+H]+; N-{[4-hydroxy-5-(hydroxymethyl)-3-(piperidin-1-yl)oxolan-2-yl]methyl}morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.097; KDSQYJRKKPZTGS-UHFFFAOYSA-N; [M+H]+; 2-[6-hydroxy-5-({[(propan-2-yl)carbamoyl]amino}methyl)-hexahydrofuro[3,2-b]furan-2-yl]-N-(propan-2-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.097; VEEOQPGMBXUVDQ-UHFFFAOYSA-N; [M+H]+; 2-(6-hydroxy-5-{[(propylcarbamoyl)amino]methyl}-hexahydrofuro[3,2-b]furan-2-yl)-N-(propan-2-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.097; WAQKSLBVYZATBA-UHFFFAOYSA-N; [M+H]+; 2-[6-hydroxy-5-({[(propan-2-yl)carbamoyl]amino}methyl)-hexahydrofuro[3,2-b]furan-2-yl]-N-propylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; GRCBRFWADWMAHC-UHFFFAOYSA-N; [M+H]+; N-(4-hydroxy-5-{[2-(methoxymethyl)pyrrolidin-1-yl]methyl}oxolan-3-yl)morpholine-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; ZFJKCCADKFZVQF-UHFFFAOYSA-N; [M+H]+; [2-hydroxy-3-[2-hydroxybutyl-[2-(2-oxoimidazolidin-1-yl)ethyl]amino]propyl] 2-methylprop-2-enoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -324.787; KDSQYJRKKPZTGS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -326.009; WAQKSLBVYZATBA; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -352.098; VEEOQPGMBXUVDQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -356.134; GRCBRFWADWMAHC; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -361.865; FTEQMUXMWCGJAF; [M+H]+; 1-[4-[4-(4,6-dimethyl-1,3,5-triazin-2-yl)-2,6-dimethylpiperazin-1-yl]pyrimidin-2-yl]ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -391.792; KMKUXKWHHGYRTE; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.053; KDSQYJRKKPZTGS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -134.738; VQZJYJZTRAJHED; [M+H]+; N-[(5-isobutyl-1,2,4-oxadiazol-3-yl)methyl]-6-isopropyl-N,1-dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -143.356; BTSPONZHXJSJIG; [M+H]+; N-[(3-isobutyl-1,2,4-oxadiazol-5-yl)methyl]-N,1-dimethyl-6-propyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -154.747; BBIIACOEUOSKPA; [M+H]+; 3-Cyclopropyl-5-[4-(5,6-diethyl-1,2,4-triazin-3-yl)-1-methylpiperazin-2-yl]-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -156.989; CLLMGHWGAOLZPU; [M+H]+; trans-3-(4-cyclopropyl-5-{[[(3-cyclopropyl-1,2,4-oxadiazol-5-yl)methyl](methyl)amino]methyl}-4H-1,2,4-triazol-3-yl)cyclobutanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -157.391; PNISKNZCYBSFPK; [M+H]+; N4-cyclopropyl-N6,N6-dimethyl-N4-{1-[(1,2,4-oxadiazol-5-yl)methyl]piperidin-4-yl}pyrimidine-4,6-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -158.354; LJNHWSSLMXRRMH; [M+H]+; N-ethyl-N'-[2-(3-methyl-1,2,4-oxadiazol-5-yl)ethyl]-4-pyridin-2-ylpiperazine-1-carboximidamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -158.691; OIFKIJOGHCFDKX; [M+H]+; 3-[[2-(Cyclopropylmethoxy)pyridin-4-yl]methyl]-1,2-dimethyl-1-[(2-methyl-1,2,4-triazol-3-yl)methyl]guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -160.458; FGUKZYJURFZIGZ; [M+H]+; N4-cyclopropyl-N6,N6-dimethyl-N4-[1-(3-methyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl]pyrimidine-4,6-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -161.800; YGPWGDSZOQQTQM; [M+H]+; N4-cyclopropyl-N6,N6-dimethyl-N4-{1-[(1,3,4-oxadiazol-2-yl)methyl]piperidin-4-yl}pyrimidine-4,6-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -162.054; OBWOCZNLZMEMFX; [M+H]+; N-[2-(5-isopropyl-1,2,4-oxadiazol-3-yl)ethyl]-N,1-dimethyl-6-propyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.156; VQZJYJZTRAJHED; [M+H]+; N-[(5-isobutyl-1,2,4-oxadiazol-3-yl)methyl]-6-isopropyl-N,1-dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C16H30N3O5; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(2), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 4.192
MS$FOCUSED_ION: PRECURSOR_M/Z 344.217998
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00di-0900000000-c60e029ead07ddee70a8
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  70.0652037 15.8850 70.065947 1.4701 6.88 0.0238 10 f{C4H8N1}/1.11ppm,p-C12H22N2O5
  72.0808027 16.2185 72.081546 1.2763 4.43 0.1429 9 f{C4H10N1}/0.37ppm,p-C12H20N2O5
  107.0728865 15.1615 107.073429 1.4196 3.68 0.6429 10 f{C7H9N1}/-0.60ppm,p-C9H21N2O5
  108.0808423 25.1971 108.081378 0.9807 5.30 0.5000 10 f{C7H10N1}/0.62ppm,p-C9H20N2O5
  120.0806681 39.1635 120.081107 1.0077 4.96 0.7619 9 f{C8H10N1}/-0.90ppm,p-C8H20N2O5
  122.0964558 999.0000 122.096875 0.3440 0.00 0.7333 12 f{C8H12N1}/0.25ppm,p-C8H18N2O5
  123.0998491 77.0831 123.100258 1.1535 8.44 0.4333 12 ?
  150.0912290 12.9775 150.091530 1.2925 3.12 0.8214 9 f{C9H12N1O1}/-0.74ppm,p-C7H18N2O4
  165.1386311 140.4818 165.138974 0.3633 7.16 0.6333 12 f{C10H17N2}/0.04ppm,p-C6H13N1O5
  299.1599815 97.0362 299.160390 0.9627 6.77 0.8929 10 f{C14H23N2O5}/-0.56ppm,p-C2H7N1
  300.1628019 14.4425 300.163211 1.9090 3.86 0.3143 9 ?
  344.2177550 25.1917 344.218191 1.6501 7.22 1.0000 9 f{C16H30N3O5}/-0.70ppm,p
PK$NUM_PEAK: 12
PK$PEAK: m/z int. rel.int.
  70.065204 15.88 15
  72.080803 16.22 16
  107.072887 15.16 15
  108.080842 25.20 25
  120.080668 39.16 39
  122.096456 999.00 999
  123.099849 77.08 77
  150.091229 12.98 12
  165.138631 140.48 140
  299.159981 97.04 97
  300.162802 14.44 14
  344.217755 25.19 25
//
